1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Dahiyat, B.I. Sarisky, C.A. Mayo, S.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 273 789 796 10.1006/jmbi.1997.1341 9367772 De novo protein design: towards fully automated sequence selection. 1997 US Science SCIEAS 0038 0036-8075 278 82 De Novo Protein Design: Fully Automated Sequence Selection 1997 10.2210/pdb1psv/pdb pdb_00001psv 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 DESIGNED PEPTIDE 3368.819 PDA8D 1 syn polymer no no KPYTARIKGRTFSNEKELRDFLETFTGR KPYTARIKGRTFSNEKELRDFLETFTGR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-01-28 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1997-10-29 REL SEQUENCE SELECTED BY DEAD END ELIMINATION sample NO RESTRAINT VIOLATIONS GREATER THAN 0.3 ANGSTROMS, RMS DEVIATIONS FROM IDEALIZED BOND LENGTHS < 0.01 A, AND RMS DEVIATIONS FROM IDEALIZED ANGLES AND IMPROPERS < 1.0 DEGREE 98 32 NOESY TOCSY DQF-COSY 5.0 280 K SEE JRNL CITATION ABOVE. HYBRID DISTANCE GEOMETRY-SIMULATED ANNEALING BRUNGER refinement X-PLOR structure solution ANSIG structure solution X-PLOR 600 Varian UNITYPLUS 600 LYS 1 n 1 LYS 1 A PRO 2 n 2 PRO 2 A TYR 3 n 3 TYR 3 A THR 4 n 4 THR 4 A ALA 5 n 5 ALA 5 A ARG 6 n 6 ARG 6 A ILE 7 n 7 ILE 7 A LYS 8 n 8 LYS 8 A GLY 9 n 9 GLY 9 A ARG 10 n 10 ARG 10 A THR 11 n 11 THR 11 A PHE 12 n 12 PHE 12 A SER 13 n 13 SER 13 A ASN 14 n 14 ASN 14 A GLU 15 n 15 GLU 15 A LYS 16 n 16 LYS 16 A GLU 17 n 17 GLU 17 A LEU 18 n 18 LEU 18 A ARG 19 n 19 ARG 19 A ASP 20 n 20 ASP 20 A PHE 21 n 21 PHE 21 A LEU 22 n 22 LEU 22 A GLU 23 n 23 GLU 23 A THR 24 n 24 THR 24 A PHE 25 n 25 PHE 25 A THR 26 n 26 THR 26 A GLY 27 n 27 GLY 27 A ARG 28 n 28 ARG 28 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 10 A A O H LEU LEU 18 22 1.60 15 A A O H LEU LEU 18 22 1.51 16 A A O H LEU LEU 18 22 1.46 18 A A O H LEU LEU 18 22 1.55 19 A A O H LEU LEU 18 22 1.59 20 A A O H LEU LEU 18 22 1.51 21 A A O H LEU LEU 18 22 1.43 22 A A O H LEU LEU 18 22 1.43 23 A A O H LEU LEU 18 22 1.47 25 A A O H LEU LEU 18 22 1.49 26 A A O H LEU LEU 18 22 1.46 27 A A O H ILE GLY 7 9 1.58 28 A A O H LEU LEU 18 22 1.53 29 A A O H LEU LEU 18 22 1.47 31 A A O H LEU LEU 18 22 1.40 32 A A O H LEU LEU 18 22 1.40 1 A THR 4 -167.39 64.86 1 A LYS 8 -159.65 10.66 1 A THR 11 64.87 149.64 1 A THR 24 -97.46 46.57 2 A TYR 3 -60.82 -176.04 2 A THR 4 -170.23 -50.25 2 A ALA 5 63.69 132.11 2 A LYS 8 -161.04 8.89 2 A THR 11 65.71 146.80 2 A THR 24 -98.03 44.98 3 A THR 4 -155.90 70.38 3 A LYS 8 -157.45 9.28 3 A THR 11 65.34 148.09 3 A THR 24 -94.10 44.63 4 A TYR 3 -63.82 -179.48 4 A THR 4 -171.89 -47.40 4 A ALA 5 64.22 132.47 4 A LYS 8 -160.17 8.30 4 A THR 11 65.45 146.84 4 A THR 24 -96.93 47.26 5 A THR 4 -168.46 -51.21 5 A ALA 5 61.74 133.88 5 A THR 11 65.06 148.48 5 A THR 24 -98.49 47.83 5 A PHE 25 -142.92 -46.58 6 A THR 4 -161.53 -50.77 6 A ALA 5 63.90 135.77 6 A ILE 7 -120.65 -67.10 6 A LYS 8 -143.45 10.89 6 A THR 11 64.70 150.10 6 A THR 24 -97.36 48.54 6 A PHE 25 -137.69 -45.68 7 A THR 4 -174.44 70.93 7 A LYS 8 -145.05 -0.81 7 A THR 11 83.36 -23.25 7 A PHE 12 53.15 116.32 7 A THR 24 -100.68 46.85 7 A THR 26 -146.81 31.65 8 A THR 4 -158.30 75.84 8 A LYS 8 -156.34 7.12 8 A THR 11 64.68 129.79 8 A THR 24 -101.86 44.94 9 A THR 4 -155.25 72.30 9 A ILE 7 -120.74 -64.39 9 A LYS 8 -144.65 10.02 9 A THR 11 64.84 152.09 9 A THR 24 -99.47 43.98 9 A PHE 25 -145.52 28.44 10 A THR 11 64.24 149.00 10 A THR 24 -97.96 45.80 10 A PHE 25 -151.95 -46.98 11 A PRO 2 -72.59 -167.50 11 A THR 4 -156.89 76.77 11 A LYS 8 -174.15 -32.67 11 A THR 11 65.19 130.82 11 A THR 24 -99.77 43.41 12 A THR 4 -173.83 72.24 12 A ALA 5 -47.27 163.80 12 A ARG 6 -92.16 41.70 12 A LYS 8 -155.80 9.72 12 A THR 11 82.75 -28.13 12 A PHE 12 54.12 116.60 12 A THR 24 -99.98 46.21 12 A PHE 25 -158.87 35.59 13 A THR 4 -170.61 -38.98 13 A ALA 5 59.98 153.64 13 A ARG 6 -89.69 46.02 13 A LYS 8 -158.47 9.99 13 A THR 11 83.25 -36.14 13 A PHE 12 53.50 111.55 13 A THR 24 -98.44 47.61 13 A PHE 25 -130.96 -55.95 14 A THR 4 -158.38 73.07 14 A LYS 8 -152.68 6.30 14 A THR 11 65.03 149.64 14 A THR 24 -104.91 46.24 14 A THR 26 -142.97 38.23 15 A TYR 3 -56.89 173.94 15 A THR 4 -172.73 63.59 15 A ARG 6 -69.69 69.65 15 A ILE 7 -125.22 -65.95 15 A LYS 8 -141.15 10.15 15 A THR 11 90.84 -37.48 15 A PHE 12 54.07 168.59 15 A THR 24 -98.10 47.41 15 A PHE 25 -138.90 -46.37 16 A THR 4 -173.78 67.69 16 A ALA 5 -45.09 158.46 16 A ARG 6 -86.63 46.85 16 A LYS 8 -156.76 9.78 16 A THR 11 80.31 -34.90 16 A PHE 12 54.49 111.44 16 A THR 24 -97.37 48.76 16 A PHE 25 -148.60 -55.15 17 A TYR 3 -59.89 176.89 17 A THR 4 -172.29 62.97 17 A LYS 8 -156.89 8.85 17 A THR 11 90.15 -37.99 17 A PHE 12 48.93 101.62 17 A THR 24 -96.68 45.35 18 A THR 4 -171.01 -32.49 18 A ALA 5 64.22 148.58 18 A ILE 7 -137.22 -147.45 18 A THR 11 84.23 -34.28 18 A PHE 12 53.64 110.13 18 A THR 24 -97.71 47.38 19 A TYR 3 -56.82 -179.12 19 A THR 4 -164.63 -38.91 19 A ALA 5 60.24 160.87 19 A LYS 8 57.55 -61.53 19 A THR 11 64.64 153.80 19 A THR 24 -96.98 47.83 19 A PHE 25 -146.02 -55.56 20 A TYR 3 -59.24 174.27 20 A THR 4 -172.01 -38.13 20 A ALA 5 62.33 152.10 20 A ILE 7 -129.93 -143.93 20 A THR 11 65.22 145.72 20 A THR 24 -98.66 47.16 20 A PHE 25 -152.72 -54.24 21 A LYS 8 -159.98 8.67 21 A THR 11 64.78 148.88 21 A THR 24 -98.13 48.41 21 A PHE 25 -147.45 -59.11 22 A THR 4 -175.89 66.76 22 A ALA 5 -45.84 159.35 22 A ARG 6 -87.03 47.06 22 A LYS 8 -156.89 10.11 22 A THR 11 81.01 -35.91 22 A PHE 12 54.36 113.70 22 A THR 24 -99.17 47.17 22 A PHE 25 -157.71 34.30 23 A PRO 2 -71.08 -87.16 23 A THR 4 -176.17 68.53 23 A LYS 8 -157.42 9.53 23 A THR 11 81.13 -35.34 23 A PHE 12 54.66 114.63 23 A THR 24 -96.97 49.87 23 A PHE 25 -131.36 -49.24 24 A THR 4 -176.66 69.97 24 A LYS 8 -171.07 -37.83 24 A THR 11 82.37 -30.78 24 A PHE 12 53.57 113.40 24 A THR 24 -103.01 43.12 25 A THR 4 -170.53 -41.18 25 A ALA 5 63.34 135.12 25 A LYS 8 -173.65 -36.09 25 A THR 11 82.96 -36.85 25 A PHE 12 54.27 109.27 25 A THR 24 -98.75 47.11 25 A PHE 25 -154.78 -60.68 26 A ALA 5 53.40 -177.11 26 A ARG 6 -97.76 38.85 26 A ILE 7 -123.90 -150.41 26 A THR 11 83.97 -39.62 26 A PHE 12 54.90 117.22 26 A THR 24 -99.67 45.46 26 A PHE 25 -159.15 37.16 27 A THR 4 -161.78 72.82 27 A LYS 8 54.95 -60.58 27 A THR 11 64.22 158.62 27 A THR 24 -96.96 38.76 28 A TYR 3 -63.66 -175.80 28 A THR 4 -175.15 -26.56 28 A ALA 5 64.30 151.19 28 A LYS 8 52.95 -81.16 28 A THR 11 82.32 -36.39 28 A PHE 12 49.46 102.29 28 A THR 26 -154.53 29.03 29 A THR 4 -172.90 81.86 29 A ALA 5 -45.80 170.41 29 A LYS 8 59.81 -60.54 29 A THR 11 82.43 -15.16 29 A PHE 12 43.42 108.68 29 A ASN 14 -172.69 -164.28 29 A THR 24 -98.92 48.47 29 A PHE 25 -147.37 -50.88 30 A TYR 3 -63.87 -177.95 30 A THR 4 -174.07 -31.71 30 A ALA 5 63.78 159.98 30 A ARG 6 -86.10 44.70 30 A ILE 7 -125.35 -144.32 30 A THR 11 86.60 -35.61 30 A PHE 12 48.84 100.75 31 A THR 4 -174.46 76.45 31 A ALA 5 -47.23 159.99 31 A LYS 8 63.78 -55.12 31 A THR 11 84.01 -20.27 31 A PHE 12 51.63 112.03 31 A LEU 22 -39.09 -32.32 31 A THR 24 -101.41 58.55 31 A PHE 25 -136.25 -43.70 32 A THR 4 179.84 -42.11 32 A ALA 5 64.24 139.86 32 A LYS 8 64.10 -62.94 32 A THR 11 65.66 142.34 32 A SER 13 -26.77 -42.40 32 A THR 24 -100.46 40.61 32 A THR 26 -153.46 43.75 model building X-PLOR refinement X-PLOR phasing X-PLOR COMPUTATIONALLY DESIGNED PEPTIDE WITH A BETA-BETA-ALPHA FOLD SELECTION, NMR, 32 STRUCTURES 1 Y N A GLU 15 A GLU 15 HELX_P A GLU 23 A GLU 23 1 1 9 DESIGNED PEPTIDE PROTEIN DESIGN, DEAD END ELIMINATION, BETA-BETA-ALPHA FOLD, SEQUENCE OPTIMIZATION, DESIGNED PEPTIDE 1PSV PDB 1 1PSV 1 28 1PSV 1 28 1PSV A 1 1 28 1 P 1